Folate Testing
This reimbursement policy governs coverage criteria for serum and red blood cell folate testing and folate receptor autoantibody testing for BlueCross BlueShield of Tennessee members; applicability depends on individual benefits and relevant Medicare/Medicaid rules.
No material clinical or coverage changes in this revision.
Coverage Determinations
Coverage criteria
Coverage determinations depend on individual benefits and applicable government policies; see Medicare/Medicaid sections for specifics.
ALL of the following
- Patient has a diagnosis of megaloblastic or macrocytic anemia.
- The megaloblastic anemia and/or macrocytosis does not resolve after folic acid treatment.
- Measurement of serum folate concentration is ordered to evaluate the unresolved megaloblastic or macrocytic anemia.
Not covered (DOES NOT MEET COVERAGE CRITERIA)
- Measurement of serum folate concentration for indications other than unresolved megaloblastic or macrocytic anemia.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.